/INFU

InfuSystem Holdings Inc

INFU

$12.15USD↑+0.25%+0.03 today

MARKET CAP

242.0M

P/E (TTM)

32.8x

FWD P/E

—

DAY RANGE

$12 – $12

52W RANGE

$7

$13

AI Summary

Stalk

StalkMedium

Following INFU’s robust early August momentum breakout, price is tightly consolidating near rising 9- and 20-EMA support with EMAs in bullish alignment. Medium-term bullish structure remains intact while short-term timing is neutral, warranting patience and stalking for a pullback entry into the 9/20 EMA zone.

↑Q2 revenue $36.9M, up 2.6% YoY (~7.5% ex restructuring) driven by oncology volume
↑Wound care revenue jumped 154% YoY to $2.1M on compression devices
↓GE contract restructuring trimmed Q2 revenue by $1.6M, highlighting partnership risk

Full analysis →

Buying

3

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.59 M	15.30 M	+968.83 K	+168.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	543.01 K	5.24 M	+-23.80 K	+0.2%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	180.65 K	1.74 M	+10.70 K	+11.1%	0.00%
MG Man Group Plc Q2 2026	BUY	130.38 K	1.26 M	+18.27 K	+21.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	9.08 K	89.69 K	+-818.00	-3.1%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-354.56 K	-100.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-51.03 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-14.04 K	-100.0%	0.00%